An evidence-based review of the incidence of CNS bleeding with anti-VEGF therapy in non-small cell lung cancer patients with brain metastasesSANDLER, Alan; HIRSH, Vera; RECK, Martin et al.Lung cancer. 2012, Vol 78, Num 1, pp 1-7, issn 0169-5002, 7 p.Article

The role of topotecan in treating small cell lung cancer: second-line treatmentVON PAWEL, Joachim.Lung cancer. 2003, Vol 41, pp S3-S8, issn 0169-5002, SUP4Article

The emerging role of MET/HGF inhibitors in oncologySCAGLIOTTI, Giorgio V; NOVELLO, Silvia; VON PAWEL, Joachim et al.Cancer treatment reviews. 2013, Vol 39, Num 7, pp 793-801, issn 0305-7372, 9 p.Article

Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non―Small-Cell Lung Cancer: A Phase III TrialSCAGLIOTTI, Giorgio V; KRZAKOWSKI, Maciej; PAPAI, Zsolt S et al.Journal of clinical oncology. 2012, Vol 30, Num 17, pp 2070-2078, issn 0732-183X, 9 p.Article

Long-term Stability of Circulating Nucleosomes in SerumHOLDENRIEDER, Stefan; VON PAWEL, Joachim; NAGEL, Dorothea et al.Anticancer research. 2010, Vol 30, Num 5, pp 1613-1615, issn 0250-7005, 3 p.Conference Paper

Circulating nucleosomes predict the response to chemotherapy in patients with advanced non-small cell lung cancerHOLDENRIEDER, Stefan; STIEBER, Petra; VON PAWEL, Joachim et al.Clinical cancer research. 2004, Vol 10, Num 18, pp 5981-5987, issn 1078-0432, 7 p.Article

Efficacy and safety of first-line erlotinib in elderly patients with advanced non-small cell lung cancerMERIMSKY, Ofer; CHENG, Chi-Kin; SIU-KIE AU, Joseph et al.Oncology reports. 2012, Vol 28, Num 2, pp 721-727, issn 1021-335X, 7 p.Article

DISRUPT: A randomised phase 2 trial of ombrabulin (AVE8062) plus a taxane―platinum regimen as first-line therapy for metastatic non-small cell lung cancerVON PAWEL, Joachim; GORBOUNOVA, Vera; RECK, Martin et al.Lung cancer. 2014, Vol 85, Num 2, pp 224-229, issn 0169-5002, 6 p.Article

Clinical Relevance of Thymidine Kinase for the Diagnosis, Therapy Monitoring and Prognosis of Non-operable Lung CancerHOLDENRIEDER, Stefan; VON PAWEL, Joachim; DUELL, Thomas et al.Anticancer research. 2010, Vol 30, Num 5, pp 1855-1862, issn 0250-7005, 8 p.Conference Paper

Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin : Quality of life and 6-years'-follow-up results from a randomised phase III trialRECK, Martin; VON PAWEL, Joachim; MACHA, Hans-Nicholas et al.Lung cancer. 2006, Vol 53, Num 1, pp 67-75, issn 0169-5002, 9 p.Article

Randomized phase III trial of paclitaxel, etoposide, and carboplatin versus carboplatin, etoposide, and vincristine in Patients with small-cell lung cancerRECK, Martin; VON PAWEL, Joachim; MACHA, Hans-Nicolas et al.Journal of the National Cancer Institute. 2003, Vol 95, Num 15, pp 1118-1127, issn 0027-8874, 10 p.Article

Long-term survival in SCLC after treatment with paclitaxel, carboplatin and etoposide: A phase II studyRECK, Martin; JAGOS, Urzula; GRUNWALD, Franziska et al.Lung cancer. 2003, Vol 39, Num 1, pp 63-69, issn 0169-5002, 7 p.Article

Prospective, multicenter, randomized, independent-group, open-label phase II study to investigate the efficacy and safety of three regimens with two doses of sagopilone as second-line therapy in patients with stage IIIB or IV non-small-cell lung cancerHEIGENER, David F; VON PAWEL, Joachim; ESCHBACH, Corinna et al.Lung cancer. 2013, Vol 80, Num 3, pp 319-325, issn 0169-5002, 7 p.Article

Randomized phase II study of three doses of the integrin inhibitor cilengitide versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancerMANEGOLD, Christian; VANSTEENKISTE, Johan; CARDENAL, Felipe et al.Investigational new drugs. 2013, Vol 31, Num 1, pp 175-182, issn 0167-6997, 8 p.Article

Nucleosomes and CYFRA 21-1 indicate tumor response after one cycle of chemotherapy in recurrent non-small cell lung cancerHOLDENRIEDER, Stefan; VON PAWEL, Joachim; RAITH, Hannelore et al.Lung cancer. 2009, Vol 63, Num 1, pp 128-135, issn 0169-5002, 8 p.Article

Pemetrexed in the treatment of malignant mesothelioma: Results from an expanded access program in GermanyRECK, Martin; STAHEL, Rolf A; MANEGOLD, Christian et al.Respiratory medicine. 2010, Vol 104, Num 1, pp 142-148, issn 0954-6111, 7 p.Article

Phase II study of ASA404 (vadimezan, 5,6-dimethylxanthenone-4-acetic acid/DMXAA) 1800 mg/m² combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancerMCKEAGE, Mark J; RECK, Martin; JAMESON, Michael B et al.Lung cancer. 2009, Vol 65, Num 2, pp 192-197, issn 0169-5002, 6 p.Article

Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non-Small-Cell Lung Cancer : AVAiLRECK, Martin; VON PAWEL, Joachim; MANEGOLD, Christian et al.Journal of clinical oncology. 2009, Vol 27, Num 8, pp 1227-1234, issn 0732-183X, 8 p.Article

Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in Monitoring First-Line Chemotherapy of Small Cell Lung CancerHOLDENRIEDER, Stefan; VON PAWEL, Joachim; RAITH, Hannelore et al.Clinical cancer research (Print). 2008, Vol 14, Num 23, pp 7813-7821, issn 1078-0432, 9 p.Article

Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer : The tarceva lung cancer investigation trialPLUZANSKA, Anna; SZCZESNA, Aleksandra; JANASKOVA, Terezie et al.Journal of clinical oncology. 2007, Vol 25, Num 12, pp 1545-1552, issn 0732-183X, 8 p.Article

A randomized, double-blind, placebo-controlled phase 2 study of tigatuzumab (CS-1008) in combination with carboplatin/paclitaxel in patients with chemotherapy-naïve metastatic/unresectable non-small cell lung cancerRECK, Martin; KRZAKOWSKI, Maciej; CHMIELOWSKA, Ewa et al.Lung cancer. 2013, Vol 82, Num 3, pp 441-448, issn 0169-5002, 8 p.Article

Phase III Trial Comparing Carboplatin, Paclitaxel, and Bexarotene With Carboplatin and Paclitaxel in Chemotherapy-Naive Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer : SPIRIT IIBLUMENSCHEIN, George R; KHURI, Fadlo R; NEGRO-VILAR, Andres et al.Journal of clinical oncology. 2008, Vol 26, Num 11, pp 1879-1885, issn 0732-183X, 7 p.Article

Technical performance and diagnostic utility of the new elecsys® neuron-specific enolase enzyme immunoassayMULEY, Thomas; EBERT, Werner; GURR, Eberhard et al.Clinical chemistry and laboratory medicine. 2003, Vol 41, Num 1, pp 95-103, issn 1434-6621, 9 p.Article

Phase II comparator study of oral versus intravenous topotecan in patients with chemosensitive small-cell lung cancerVON PAWEL, Joachim; GATZEMEIER, Ulrich; LANE, Stephen et al.Journal of clinical oncology. 2001, Vol 19, Num 6, pp 1743-1749, issn 0732-183XArticle

Effect of chemotherapy for advanced non-small cell lung cancer on patients' quality of life : A randomized controlled trialBELANI, Chandra P; PEREIRA, Jose R; MILLWARD, Michael et al.Lung cancer. 2006, Vol 53, Num 2, pp 231-239, issn 0169-5002, 9 p.Article